True statement about Pneumocystic Jiroveci is:
**Question:** True statement about Pneumocystic Jiroveci is:
A. Pneumocystis jiroveci is a fungus.
B. Pneumocystis jiroveci infection is also known as Pneumocystis pneumonia.
C. The infection is more common in immunocompromised patients.
D. The infection is rare in healthy individuals.
**Core Concept:** Pneumocystis jiroveci is a fungus that can cause a severe pneumonia called Pneumocystis pneumonia (PCP). PCP is more common in individuals with impaired immune systems, as the fungus thrives in the setting of decreased immune function.
**Why the Correct Answer is Right:**
Pneumocystis jiroveci is indeed a fungus, belonging to the family Pneumocystidaceae and classified under the order Mucorales. Its presence in the respiratory tract is common and asymptomatic in healthy individuals, as their immune systems can control the infection efficiently. However, in immunocompromised patients, the immune response to Pneumocystis jiroveci is compromised, allowing the fungus to proliferate and cause PCP.
**Why Each Wrong Option is Incorrect:**
A. While true that Pneumocystis jiroveci is a fungus, the statement is too broad and does not address the specific context of the infection.
B. Although the infection is known as Pneumocystis pneumonia (PCP), the statement is incorrect as it incorrectly suggests that PCP is a separate entity from the fungus itself.
C. The correct statement should read, "The infection is more common in immunocompromised patients," not "the infection is rare in healthy individuals." This highlights the context of the infection and its association with immunosuppressed patients.
D. This statement is incorrect as Pneumocystis jiroveci pneumonia is a severe infection that occurs in immunocompromised patients, not a rarity in healthy individuals.
**Clinical Pearl:**
In cases of severe PCP, it is essential for clinicians to consider immunocompromised patients as the primary risk group, as they are more susceptible to developing the infection due to compromised immune systems. Early diagnosis and prompt treatment are crucial to improve outcomes in these patients.